Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

6(85.7%)

Phase 2

1(14.3%)

7Total

N/A(6)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06359587Not ApplicableRecruiting

Re-Purposing the Ordering of Routine Laboratory Tests in Hospitals in British Columbia

Role: collaborator

NCT04894435Phase 2Active Not Recruiting

Mix and Match of the COVID-19 Vaccine for Safety and Immunogenicity

Role: collaborator

NCT05664724Not ApplicableUnknown

Simultaneous Physiotherapy and Orthopedic Surgeon Interdisciplinary Care (SPOSIC)

Role: collaborator

NCT04063917Not ApplicableCompleted

Safety, and Tolerability of the ZENS Device (PLUTO)

Role: collaborator

NCT03485872Not ApplicableCompleted

Urinary Incontinence Self-Screen for Healthy Aging

Role: collaborator

NCT03512483Not ApplicableWithdrawn

VCH -- vAFC Phase 3

Role: collaborator

NCT03270449Not ApplicableCompleted

Community-based Intervention for Fibromyalgia: A Pilot Trial

Role: collaborator

All 7 trials loaded